Am J Transplant, Volume 17, Suppl 3 Archives - Page 48 of 181 - ATC Abstracts

2017 American Transplant Congress
Temporal Trends and Variation in BMI Thresholds for Living Donation Across the US.
A. Naik,¹ D. Cibrik,¹ A. Sakhuja,² K. Lentine.³
¹U Michigan, Ann Arbor; ²Mayo Clinic, Rochester; ³St. Louis U, St Louis
The acceptable BMI threshold for living kidney donation is controversial. We examined the variability in center acceptance of living donors with high Body Mass Index…
2017 American Transplant Congress
Current Practice and Center-Level Variation in Simultaneous Liver-Kidney Listing.
X. Luo, A. Massie, J. Garonzik-Wang, R. Choudhury, A. Shaffer, S. Zhou, D. Segev.
Johns Hopkins, Baltimore, MD
The OPTN has proposed medical eligibility criteria to determine which transplant candidates are appropriate for SLK vs liver-alone transplantation. We investigated center variation of SLK…
2017 American Transplant Congress
MELD Exception Score: LSAM Modeling of a Fixed Floor.
J. Heimbach,¹ R. Hirose,² D. Schladt,³ J. Pyke,³ J. Zeglin,³ S. Leppke,³ J. Lake,⁴ W. Kim.^5,3
¹Mayo Clinic, Rochester; ²UCSF, San Francisco; ³SRTR, Minneapolis; ⁴Univ of Minnesota, Minneapolis; ⁵Stanford Univ, Stanford
Current US liver allocation policy grants standard MELD score exceptions beginning at 22 points and rising every 3 months. Scores for hepatocellular cancer are delayed…
2017 American Transplant Congress
Using Donors with False Positive HIV Tests – An Unexpected Benefit of the HOPE Act.
C. Durand,¹ S. Halpern,¹ G. Bismut,¹ B. Doby,¹ N. Desai,¹ A. Cameron,¹ S. Florman,² S. Lerner,² S. Huprikar,² J. Locke,³ S. Mehta,³ P. Stock,⁴ N. Neidlinger,⁵ D. Brown,¹ B. Haydel,² A. Redd,^1,6 A. Massie,¹ A. Tobian,¹ D. Segev.¹
¹JHU, Baltimore, MD; ²Mount Sinai, New York, NY; ³UAB, Birmingham, AL; ⁴UCSF, San Francisco, CA; ⁵Donor Network West, San Ramon, CA; ⁶NIH, Bethesda, MD
Deceased donors are screened for HIV infection using anti-HIV antibody (Ab) and nucleic acid testing (NAT). Historically, organs were discarded in cases of a suspected…
2017 American Transplant Congress
When Does the Learning Curve End? A High-Volume Single Center Experience with Laparoscopic Donor Nephrectomy Over 16 Years.
S. Yamanaga,^1,2,3 A. Posselt,¹ C. Freise,¹ C. Niemann,¹ A. Rosario,¹ D. Fernandez,¹ T. Kobayashi,³ A. Ahearn,⁴ M. Tavakol,¹ S.-M. Kang.¹
¹Division of Transplant Surgery, Department of Surgery, University of California San Francisco, San Francisco, CA; ²Department of General Surgery, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan; ³Department of Renal Transplant Surgery, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan; ⁴Department of Transplant Surgery, UMass Memorial Medical Center, Worcester, MA
Purpose: No studies for any type of surgery have examined learning curves beyond a decade or 100 cases because surgeon turnover and lack of complete…
2017 American Transplant Congress
Donation After Circulatory Death (DCD) Kidneys Are More Likely to Be Discarded than Kidneys from Neurologically Brain Dead Donors (NBD).
J. Gill,¹ C. Rose,¹ J. Lesage,¹ Y. Joffres,¹ J. Gill,¹ K. O'Connor.²
¹UBC, Vancouver, Canada; ²LifeCenter, Seattle
Strategies to decrease organ discard are needed. We determined the adj odds of discard of DCD vs NBD kidneys in kidney donor profile index (KDPI)…
2017 American Transplant Congress
Cultural Competency of a Mobile, Customized Patient Education Tool for Improving Potential Kidney Transplant Recipients' Knowledge and Decision-Making.
D. Axelrod,¹ C. Kynard-Amerson,² D. Wojciechowski,³ K. Lentine,⁴ M. Schnitzler,⁴ J. Peipert,² A. Waterman.²
¹Surgery, East Carolina University, Greenville, NC; ²Medicine, UCLA, Los Angeles, CA; ³Medicine, Massachusetts General Hospital, Boston, MA; ⁴Transplant, Saint Louis University, St. Louis, MO
Patients with ESRD face a complex array of treatment options as a result of the revised kidney allocation system. Decision aids improve patient care through…
2017 American Transplant Congress
Is There an Association Between Number of Outpatient Primary Care Visits (OPV) and Outcomes in Kidney Transplantation (KTP)?
A. O'Shea, R. Kalil.
Medicine, University of Iowa Carver College of Medicine, Iowa City, IA; Department of Veterans Affairs, Comprehensive Access and Delivery Research Evaluation (CADRE), Iowa City, IA
Background: Periodic outpatient primary care visits (PCV) after KTP is recommended to achieve optimal outcomes, but annual rates of PCV by KTP recipients is not…
2017 American Transplant Congress
Experience with Belatacept (CTLA4-Ig) Conversion in Highly HLA Sensitized (HS) and ABO-Incompatible (ABOi) Patients Who Received Incompatible Kidney Transplants Post Desensitization (DES).
J. Choi,¹ A. Peng,¹ A. Vo,¹ E. Huang,¹ R. Najjar,¹ S. Louie,¹ A. Kang,¹ S. Ge,¹ M. Toyoda,¹ X. Zhang,² S. Jordan.¹
¹Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA; ²HLA Laboratory, Cedars-Sinai Medical Center, Los Angeles, CA
Introduction: Recent experience with belatacept (bela) in nonsensitized kidney tx recipients suggest that costimulatory blockade in a CNI-free environment results in superior graft survival &…
2017 American Transplant Congress
The miRNome of EBV+ PTLD is Distinct from EBV+ Infectious Mononucleosis.
Y. Balachandran,¹ V. Kaul,¹ E. Maloney,¹ A. Harris-Arnold,¹ K. Weinberg,² S. Boyd,² D. Bernstein,² C. Esquivel,¹ O. Martinez,¹ S. Krams.¹
¹Transplant Immunology Lab/Division of Abdominal Transplant, Stanford University, Stanford; ²Stanford University, Stanford
Post-transplant lymphoproliferative disorder (PTLD) is a potentially fatal complication of organ transplantation commonly associated with Epstein Barr virus (EBV) infection. More than 90% of the…